ClinVar Miner

Submissions for variant NM_006920.6(SCN1A):c.4729T>C (p.Cys1577Arg) (rs121917919)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000188974 SCV000242605 likely pathogenic not provided 2016-12-21 criteria provided, single submitter clinical testing p.Cys1588Arg (TGT>CGT): c.4762 T>C in exon 25 of the SCN1A gene (NM_001165963.1) A C1588R variant that is likely pathogenic has been identified in the SCN1A gene. The C1588R variant has been reported previously as a de novo variant in a patient with Dravet syndrome (Marini et al., 2007). The C1588R variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The C1588R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution alters a conserved position that is predicted to be within the transmembrane segment S2 of the fourth homologous domain, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, missense variants in nearby residues (G1586E, V1589G) have been reported in the Human Gene Mutation Database in association with SCN1A-related disorders (Stenson et al., 2014). Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.
Invitae RCV000636318 SCV000757757 pathogenic Early infantile epileptic encephalopathy 2018-03-06 criteria provided, single submitter clinical testing This sequence change replaces cysteine with arginine at codon 1588 of the SCN1A protein (p.Cys1588Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been reported to be de novo in individuals affected with epileptic encephalopathies (PMID: 17561957, 25818041). ClinVar contains an entry for this variant (Variation ID: 68552). Loss-of-function variants in SCN1A are known to be pathogenic (PMID: 17347258, 18930999). For these reasons, this variant has been classified as Pathogenic.
UniProtKB/Swiss-Prot RCV000059426 SCV000090950 not provided Severe myoclonic epilepsy in infancy no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.